Financial reports
10-K
2023 FY
Annual report
26 Mar 24
10-Q
2023 Q3
Quarterly report
9 Nov 23
10-Q
2023 Q2
Quarterly report
10 Aug 23
10-Q
2023 Q1
Quarterly report
11 May 23
ARS
2022 FY
Annual report to shareholders
21 Apr 23
10-K
2022 FY
Annual report
22 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
15 Aug 22
10-Q
2022 Q1
Quarterly report
13 May 22
10-K
2021 FY
Annual report
17 Mar 22
Current reports
8-K
Other Events
10 Apr 24
8-K
Amendments to Articles of Incorporation or Bylaws
5 Apr 24
8-K
Results of Operations and Financial Condition
27 Mar 24
8-K
Departure of Directors or Certain Officers
6 Mar 24
8-K
Departure of Directors or Certain Officers
13 Feb 24
8-K
Entry into a Material Definitive Agreement
1 Feb 24
8-K
Palisade Bio Announces Positive Preclinical Data of Lead Program
29 Jan 24
8-K
Regulation FD Disclosure
7 Nov 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
20 Oct 23
8-K
Entry into a Material Definitive Agreement
11 Sep 23
Registration and prospectus
424B3
Prospectus supplement
5 Apr 24
S-3
Shelf registration
29 Mar 24
S-8
Registration of securities for employees
29 Mar 24
D
$2.50 mm in options / securities to be acquired, sold $2.50 mm, 15 investors
13 Feb 24
424B3
Prospectus supplement
1 Feb 24
424B3
Prospectus supplement
1 Feb 24
424B3
Prospectus supplement
1 Feb 24
424B3
Prospectus supplement
1 Feb 24
RW
Registration withdrawal request
26 Jan 24
S-1
IPO registration
29 Dec 23
Proxies
DEFA14A
Additional proxy soliciting materials
6 Feb 24
DEF 14A
Definitive proxy
6 Feb 24
PRE 14A
Preliminary proxy
26 Jan 24
DEFA14A
Additional proxy soliciting materials
21 Apr 23
DEF 14A
Definitive proxy
21 Apr 23
DEF 14A
Definitive proxy
1 Sep 22
DEF 14A
Definitive proxy
31 Aug 22
PRE 14A
Preliminary proxy
23 Aug 22
PRE 14A
Preliminary proxy
22 Aug 22
DEFA14A
Additional proxy soliciting materials
21 Apr 22
Other
EFFECT
Notice of effectiveness
8 Apr 24
EFFECT
Notice of effectiveness
28 Apr 23
CORRESP
Correspondence with SEC
27 Apr 23
UPLOAD
Letter from SEC
25 Apr 23
EFFECT
Notice of effectiveness
25 Jan 23
CORRESP
Correspondence with SEC
20 Jan 23
UPLOAD
Letter from SEC
19 Jan 23
EFFECT
Notice of effectiveness
12 Aug 22
CORRESP
Correspondence with SEC
9 Aug 22
CORRESP
Correspondence with SEC
9 Aug 22
Ownership
4
John David Finley
12 Mar 24
SC 13G/A
ARMISTICE CAPITAL, LLC
14 Feb 24
SC 13G/A
Lind Global Fund II LP
13 Feb 24
4
James R Neal
13 Feb 24
4
Cristina Csimma
13 Feb 24
4
Robert J. Trenschel
13 Feb 24
4
Stephanie Diaz
13 Feb 24
SC 13G/A
L1 Capital Global Opportunities Master Fund, Ltd.
9 Feb 24
4
Mitchell Lawrence Jones
8 Feb 24
4
John David Finley
8 Feb 24